Public Listing

Category: LISTED IPO

  • Rajnandini Fashion India

    Rajnandini Fashion India IPO: Comprehensive Guide, Financials & Valuation

    Rajnandini Fashion India IPO: Complete Valuation, Dates, and Investment Guide

    A detailed breakdown of the upcoming BSE SME listing, company financials, and market positioning to help you make an informed decision.

    The Indian apparel and textile market is buzzing with activity, and emerging players are capitalizing on shifting consumer trends toward branded ethnic and casual wear. Stepping into the spotlight is Rajnandini Fashion India Ltd., which is preparing to launch its Initial Public Offering (IPO) on the BSE SME platform.

    Scheduled to open for subscription in late May 2026, this book-built issue aims to raise ₹18.21 Crores through a completely fresh issue of shares. In this comprehensive guide, we will analyze the company’s core business model, dissect its financial health, outline the IPO timeline, and present a critical SWOT analysis to aid your investment research.

    Business Operations: What Does Rajnandini Fashion Do?

    Established in 2010, Rajnandini Fashion India Ltd. has strategically positioned itself as a versatile manufacturer, designer, and seller of women’s apparel. The company bridges the gap between traditional ethnic wear and modern casual fashion, serving an extensive clientele through diverse channels.

    Their product portfolio features a rich blend of sarees, kurtis, unstitched dress materials, tunics, maternity gowns, and tops, utilizing fabrics like silk, cotton, rayon, and poly-cotton. The business operates across two distinct segments:

    • Direct-to-Consumer (B2C): Leveraging the digital boom, the brand drives massive sales through top-tier e-commerce giants such as Amazon, Flipkart, Myntra, Nykaa, and Ajio, alongside their proprietary website. An impressive milestone includes processing over 2.8 lakh online orders in FY 2025 alone.
    • Business-to-Business (B2B): The company caters to wholesalers, retail chains, and garment processors by supplying ready-made garments and premium fabrics. This vertical stood robust, generating over ₹11.7 Crores in FY 2025.

    With a multi-brand strategy encompassing Merira, Monira, Roly Poly, and Rajnandini, their pricing remains highly competitive, generally spanning from ₹250 to ₹2,000. Backing these operations are their in-house manufacturing units located in Surat (established 2023) and Jaipur (expanded 2024), employing a dedicated workforce of over 200 personnel.

    Strategic SWOT Analysis

    Before committing capital, understanding the internal and external factors impacting the company is crucial. Here is a breakdown of the company’s strategic positioning:

    Strengths

    • Integrated in-house manufacturing across two major textile hubs (Surat & Jaipur).
    • Strong multi-channel distribution network (high e-commerce presence).
    • Diverse brand portfolio catering to multiple price points.

    Weaknesses

    • Relatively high Debt-to-Equity ratio of 0.95, indicating leverage risks.
    • Heavy reliance on third-party e-commerce platforms which can change algorithm policies.

    Opportunities

    • Rising penetration of online shopping in Tier-2 and Tier-3 Indian cities.
    • Capitalizing on the fresh IPO funds to expand manufacturing capacities and scale.

    Threats

    • Fierce competition from unorganized sector and established ethnic wear brands.
    • Rapidly shifting fashion trends requiring constant inventory updates.
    • Fluctuations in raw material (cotton, silk) pricing.

    Key IPO Offer Details

    The company is offering its shares in a structured price band. The raised capital will strictly be a fresh equity infusion into the company, meaning promoters are not offloading their existing stakes in this offering.

    ParameterDetails
    IPO Open DateMay 26, 2026
    IPO Close DateMay 29, 2026
    Issue TypeBook Built Issue SME IPO
    Face Value₹10 per share
    Price Band₹59 to ₹63 per equity share
    Total Issue Size28,90,000 shares (Aggregating ₹18.21 Crores)
    Listing ExchangeBSE SME
    Market Maker Reservation1,46,000 shares

    Category-Wise Allocation

    The net issue (excluding the market maker portion) is systematically divided among different investor categories to ensure balanced market participation.

    • Qualified Institutional Buyers (QIB): 49.78% (13,66,000 Shares)
    • Retail Individual Investors (RII): 35.13% (9,64,000 Shares)
    • Non-Institutional Investors (NII/HNI): 15.09% (4,14,000 Shares)

    Crucial Dates & Allotment Timeline

    Tracking the exact timeline is vital to ensure funds are available and mandates are approved on time. Below is the proposed schedule from the opening date through to market listing.

    IPO Opens
    May 26, 2026
    IPO Closes
    May 29, 2026
    Basis of Allotment
    June 1, 2026
    Refunds & Demat Credit
    June 2, 2026
    Listing Date
    June 3, 2026

    Investment Lot Size Requirements

    Unlike mainboard IPOs, SME IPOs have distinct minimum investment criteria based on lot sizes to protect retail investors from massive volatility. The base lot size is set at 2,000 shares. However, take special note: the minimum application for a retail investor specifies 2 lots (4,000 shares).

    Investor CategoryMinimum LotsTotal SharesInvestment Amount (at Upper Band ₹63)
    Retail Individual (Min/Max)2 Lots4,000 Shares₹2,52,000
    Small HNI (Min)3 Lots6,000 Shares₹3,78,000
    Small HNI (Max)7 Lots14,000 Shares₹8,82,000
    Big HNI (Min)8 Lots16,000 Shares₹10,08,000
    Investment Note: An initial investment of ₹2.52 Lakhs is substantial for retail categories compared to standard SME issues. Investors must assess their risk appetite and portfolio diversification rules before committing.

    Financial Health & Performance Track Record

    An in-depth look at the company’s audited financials reveals strong upward momentum in both topline revenue and bottom-line profitability over the past three fiscal years. (All figures are in ₹ Crores).

    Financial MetricFY 2023FY 2024FY 2025
    Total Assets11.7115.7425.35
    Total Income (Revenue)28.0223.6031.27
    Profit After Tax (PAT)0.372.295.05
    EBITDA1.033.797.48
    Net Worth1.954.249.29
    Total Borrowing6.197.018.84

    The company showcased stellar growth in Profit After Tax (PAT), jumping from a modest ₹0.37 Crore in FY23 to ₹5.05 Crore in FY25. Revenue has also rebounded powerfully after a slight dip in FY24.

    Key Performance Indicators & Valuations (FY25)

    Valuation determines whether an IPO is priced aggressively or leaves money on the table for incoming shareholders. Based on FY25 numbers:

    • Return on Equity (ROE): A remarkable 74.59%, showing high efficiency in generating profits from shareholder equity.
    • Return on Capital Employed (ROCE): Sturdy at 43.22%.
    • EBITDA Margin: Healthy at 24.38%.
    • Debt-to-Equity Ratio: Stands at 0.95. While acceptable, it sits at the higher end, necessitating vigilant monitoring of debt serviceability.
    • Price-to-Earnings (P/E): The pre-IPO P/E ratio is approximately 9.33x, while the post-IPO P/E dilutes slightly to 12.94x. This valuation appears reasonably aligned with typical apparel sector multipliers.

    Why is the Company Going Public?

    The funds generated through this fresh equity raise—aggregating closely to ₹18 Crores—are earmarked for several strategic expansion and consolidation purposes:

    1. Working Capital Needs (₹9.00 Cr): The majority of the proceeds will flow directly into managing inventory, scaling operations, and daily expenditures, critical for fashion-forward businesses.
    2. Debt Reduction (₹5.50 Cr): Paying off existing borrowings will significantly trim finance costs and improve net profit margins in upcoming quarters.
    3. Infrastructure Capex (₹1.41 Cr): Strategic investment toward establishing a brand new manufacturing facility to boost production capabilities.
    4. General Corporate Purposes: The balance will be preserved for unanticipated operational requirements and brand-building activities.

    Promoters, Holding Structure, and Key Contacts

    The driving force behind Rajnandini Fashion includes promoters Vikesh Sushil Lunawat, Sushil Kumar Lunawat, and Priyanka Chopra. Their collective pre-issue shareholding stands firm at 100%. Post-IPO, the promoter holding will dilute to a still-dominant 72.13%, signifying strong ongoing skin-in-the-game.

    Registrar DetailsLead Manager & Corporate Info
    Bigshare Services Pvt.Ltd.
    Email: ipo@bigshareonline.com
    (Responsible for allotment and refund processing)    		 Book Running Lead Manager: Seren Capital Pvt.Ltd.

    Registered Office: G1-41, RIICO, Tonk Road, Sitapura Industrial Area, Jaipur, Rajasthan, 302022
    Contact: cs@rfil.in | +91-7878352054

    Final Thoughts on the Rajnandini Fashion India IPO

    The Rajnandini Fashion India IPO presents a unique proposition bridging traditional manufacturing with a modern B2C digital commerce strategy. The financials reflect aggressive profit growth and a formidable ROE, although the minimum application size of ₹2.52 Lakhs naturally restricts the pool to investors with deeper pockets. Moreover, clearing debt using IPO proceeds will likely strengthen their balance sheet in the long run.

    Investors must weigh the robust margin profile and multi-channel expansion against broader fashion industry cyclicality and e-commerce platform dependencies. Align your investment size with your portfolio’s risk tolerance, and ensure you complete your ASBA or UPI mandate before the closing deadline on May 29, 2026.

  • Yaashvi Jewellers

    Yaashvi Jewellers IPO: Complete Analysis, Dates, and Financials | Publiclisting.in

    Yaashvi Jewellers IPO: In-Depth Review, Dates, Financials, and Market Analysis

    The Indian primary market continues to buzz with exciting opportunities, and the upcoming public offering from Yaashvi Jewellers Ltd. is drawing significant attention from investors. Scheduled to open for subscription on May 25, 2026, this BSE SME listing presents a unique avenue to invest in India’s ever-growing gems and jewelry sector.

    In this comprehensive guide, we will break down everything you need to know about the Yaashvi Jewellers IPO—from core business operations and financial health to vital investment dates and a detailed SWOT analysis. By the end of this read, you will have a clear, data-driven perspective on what this offering brings to the table.

    Business Overview: What Does Yaashvi Jewellers Do?

    Established in 2013, Yaashvi Jewellers Ltd. operates primarily in the manufacturing and trading of gold jewelry. Striking a balance between premium quality and affordability, the company serves both Business-to-Business (B2B) and Business-to-Consumer (B2C) segments. Recently, the company has also expanded its footprint in the retail sector.

    Core Offerings in Their Portfolio:

    • Gold Purity Segments: Expertise in crafting jewelry across various purities, including 9K, 14K, 18K, 20K, and 22K gold.
    • Machine-Made Chains: A dedicated focus on manufacturing intricate machine-made gold chains utilized in diverse jewelry designs.
    • Diversified Trading: Active trading in studded gold jewelry, diamond jewelry, fashion silver jewelry, and gold bullions.
    • Customization: Offering bespoke jewelry products tailored to specific customer preferences.
    • Quality Assurance: Strong commitment to delivering hallmarked jewelry, ensuring transparency and trust.

    Yaashvi Jewellers IPO Vital Details

    The company aims to raise an aggregate of ₹43.88 crores through a complete fresh issue of 52.86 lakh shares. There is no Offer for Sale (OFS) component, meaning all funds raised will go directly to the company. The issue type is a Fixed Price IPO.

    ParticularsDetails
    IPO Open DateMay 25, 2026
    IPO Close DateMay 27, 2026
    Face Value₹10 per share
    Issue Price₹83 per share
    Issue Size52,86,400 shares (₹43.88 Crores)
    Issue TypeFixed Price Issue
    Listing ExchangeBSE SME
    Pre-Issue Market Cap₹146.26 Crores

    IPO Timetable & Progress Schedule

    Staying on top of the allocation and listing timeline is crucial for proper capital management. Below is the scheduled timeline for the Yaashvi Jewellers offering.

    1
    IPO Opens
    May 25, 2026
    2
    IPO Closes
    May 27, 2026
    3
    Basis of Allotment
    May 29, 2026
    4
    Refunds & Credit
    June 1, 2026
    5
    Listing Date
    June 2, 2026

    Lot Size and Investment Requirements

    Because this is an SME IPO, retail investors must apply in specific lot multiples. The fundamental lot size is 1,600 shares. However, as per the structured offering details, the minimum application threshold for retail investors has been set at 2 lots.

    Investor CategoryMinimum LotsTotal SharesInvestment Amount
    Retail Individual Investors (Min/Max)2 Lots3,200 Shares₹2,65,600
    High Net-Worth Individuals (HNI – Min)3 Lots4,800 Shares₹3,98,400

    Note: Of the net offer (excluding the market maker portion), the allocation is split almost evenly, with 49.95% assigned to Non-Institutional Investors (HNI) and 50.05% allocated to Retail Investors.

    Financial Health and Track Record

    Evaluating the fundamental strength of the business is a non-negotiable step. Yaashvi Jewellers has demonstrated robust financial growth over the past three fiscal years. Between FY25 and FY26, the company recorded a substantial 51% surge in revenue and an impressive 62% jump in Profit After Tax (PAT).

    Financial Metric (in ₹ Crores)March 31, 2024March 31, 2025March 31, 2026
    Total Assets₹0.25*₹70.94₹118.23
    Total Revenue₹200.93₹297.76₹449.74
    Profit After Tax (PAT)₹1.96₹11.28₹18.28
    Net Worth₹8.75₹24.15₹43.48
    Total Borrowing₹16.25₹43.11₹65.36

    *Asset data for FY24 as restated in filings. The steep trajectory from FY25 to FY26 highlights rapid operational scaling.

    Key Performance Indicators (KPIs)

    • Return on Equity (ROE): 54.07%
    • Return on Capital Employed (ROCE): 26.73%
    • Debt-to-Equity Ratio: 1.50
    • PAT Margin: 4.08%
    • EBITDA Margin: 6.67%
    • Pre-IPO Price to Earnings (P/E) Ratio: 5.68x

    Objectives of the Issue: Where Will the Funds Go?

    The management plans to deploy the net proceeds of approximately ₹39.04 crores strategically to fuel growth and optimize the balance sheet. The allocation is outlined as follows:

    • Working Capital Requirements (₹21.50 Cr): To ensure smooth day-to-day operations and fund inventory for expanding retail demand.
    • Debt Repayment (₹11.00 Cr): To prepay or repay existing borrowings, which will help in reducing the debt-to-equity burden and minimizing interest outgo.
    • General Corporate Purposes (₹6.54 Cr): To cover strategic initiatives, operational expenses, and unforeseen contingencies.

    Promoter Holding and Valuation Details

    The company is steered by its experienced promoters, Ankita Agarwal and Ankit Aggarwal. Promoter skin-in-the-game is a crucial confidence metric for public investors.

    • Pre-Issue Promoter Holding: 94.30%
    • Post-Issue Promoter Holding: 66.01%

    This post-issue holding structure indicates that the original founders still retain a dominant majority stake, aligning their interests with those of the newly onboarded shareholders.

    Strategic SWOT Analysis

    Strengths

    • Integrated manufacturing facility allowing better quality control over gold chains.
    • Diversified product portfolio spanning from 9K to 22K gold, diamonds, and silver.
    • Strong legacy of recurring B2B clientele mixed with a growing B2C retail presence.
    • Exceptional financial growth rate, notably a 54% ROE in the recent fiscal year.

    Weaknesses

    • High Debt-to-Equity ratio of 1.50 indicates reliance on external borrowing.
    • Relatively low PAT margin (4.08%), which is customary in high-volume jewelry trading but limits cash buffer.
    • A large initial capital requirement for retail investors (minimum ₹2.65 Lakhs) limits wider retail participation.

    Opportunities

    • Reduction of existing debt through IPO proceeds will directly boost future profitability.
    • Shift of consumer preference towards organized and hallmarked jewelry brands in India.
    • Potential for aggressive retail footprint expansion in Tier-2 and Tier-3 cities.

    Threats

    • Extreme vulnerability to global gold price fluctuations and foreign exchange rates.
    • Intense competition from unorganized local players and established national jewelry brands.
    • Changes in government import duties and taxation policies regarding precious metals.

    Contact Information and Intermediaries

    For investors looking to track allotment statuses or get in touch directly regarding the offering, here are the official points of contact:

    Registered OfficePlot No. 486, Nemi Sagar Colony, Vaishali Nagar, Jaipur, Rajasthan, 302021
    Company Emailinvestor@yaashvijewellers.com
    Registrar to the IssueBigshare Services Pvt. Ltd. (Email: investor@bigshareonline.com)
    Lead ManagerSmart Horizon Capital Advisors Pvt. Ltd.
    Market MakerShreni Shares Ltd.

    Conclusion

    The Yaashvi Jewellers IPO showcases a rapidly scaling enterprise within the traditional Indian jewelry sector. With solid top-line growth, expanding retail operations, and a clear plan to utilize proceeds for debt reduction and working capital, the company aims to solidify its market position. However, prospective investors must weigh these aggressive growth metrics against sector-specific vulnerabilities, such as gold price volatility and high inherent debt levels.

    As always, understanding the fundamentals, studying the macroeconomic environment, and assessing individual risk appetite is paramount before participating in SME public offerings.

  • Bio Medica Laboratories

    Bio Medica Laboratories SME IPO Review, Dates & Financials | Publiclisting.in

    PublicListing.in

    Comprehensive Analysis: Bio Medica Laboratories SME IPO

    The Indian pharmaceutical sector continues to be a hotspot for dynamic investments. If you are tracking the SME platform for emerging opportunities, the upcoming Bio Medica Laboratories Ltd. IPO deserves your attention. Set to launch on the NSE SME board, this contract manufacturing pharma company is looking to raise capital to fund its aggressive expansion plans.

    In this detailed review, we at Publiclisting.in break down everything you need to know about the Bio Medica Laboratories IPO—from business fundamentals and financial health to exact dates, valuations, and market consensus.

    What Does Bio Medica Laboratories Do?

    Incorporated in August 2015, Bio Medica Laboratories Ltd. has carved out a niche in the B2B pharmaceutical sector. The company operates as a dedicated contract manufacturer, developing and producing a diverse array of pharmaceutical parenteral formulations tailored to specific client requirements.

    Key Highlights of their Product Portfolio:

    • Liquid Injectables: A robust lineup comprising 58 distinct products.
    • Dry-Powder Injectables: 15 specialized products under this vertical.
    • Versatile Offerings: Availability in both single-dose and multi-dose formats catering to human and veterinary healthcare.
    • Broad Spectrum: Manufacturing spans across generic drugs, branded pharmaceuticals, and Over-The-Counter (OTC) medications.

    The company currently operates two state-of-the-art manufacturing facilities in Indore, Madhya Pradesh, and proudly holds Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certifications from the local FDA.

    Key IPO Details at a Glance

    The company is aiming to raise ₹52.43 Crores through a book-built issue. This comprises a fresh equity infusion alongside an Offer for Sale (OFS) by existing shareholders.

    ParticularsDetails
    Issue TypeBook Built Issue IPO
    Total Issue Size37,72,000 shares (Aggregating up to ₹52.43 Cr)
    Fresh Issue32,06,000 shares (Aggregating up to ₹45.00 Cr)
    Offer for Sale (OFS)3,77,000 shares (Aggregating up to ₹5.24 Cr)
    Price Band₹132 to ₹139 per equity share
    Face Value₹10 per share
    Listing ExchangeNSE SME

    IPO Schedule & Timeline (Tentative)

    Timing is crucial when participating in an IPO. Below is the step-by-step timeline for the Bio Medica Laboratories offering. Keep these dates marked to ensure you don’t miss the bidding window.

    1
    IPO Opens
    May 21, 2026 (Thu)
    2
    IPO Closes
    May 25, 2026 (Mon)
    3
    Basis of Allotment
    May 26, 2026 (Tue)
    4
    Refunds / Credit
    May 27, 2026 (Wed)
    5
    Listing Date
    May 29, 2026 (Fri)

    Lot Size & Investment Requirements

    To accommodate different tiers of investors, the lot size has been structured accordingly. A single lot consists of 1,000 shares, but retail investors must bid for a minimum of 2 lots.

    Investor CategoryMinimum LotsTotal SharesInvestment Amount (at Upper Band)
    Retail Investor (Min/Max)2 Lots2,000 Shares₹2,78,000
    Small HNI (Min)3 Lots3,000 Shares₹4,17,000
    Big HNI (Min)8 Lots8,000 Shares₹11,12,000

    Financial Performance Analysis

    A closer look at the restated financials reveals a company on a steep growth trajectory. Between FY23 and FY25, total income more than doubled, while Profit After Tax (PAT) witnessed a massive leap, showcasing improved operational efficiencies and margins.

    Financial Metric (₹ in Crores)30 Nov 202531 Mar 202531 Mar 202431 Mar 2023
    Total Assets65.1739.1219.5317.57
    Total Income28.6338.3315.3416.25
    Profit After Tax (PAT)8.669.792.500.33
    Net Worth17.1214.734.942.44
    Total Borrowing38.1715.0110.499.61

    Note: The surge in borrowings up to Nov 2025 highlights the need for capital restructuring, which aligns with their IPO objectives.

    Valuation & Key Performance Indicators (KPIs)

    Understanding the valuation metrics is vital to gauge if the issue is priced reasonably. As per the latest FY25 data available in the draft papers:

    Valuation Multiples

    • Pre-IPO P/E Ratio: 13.03x
    • Post-IPO P/E Ratio: 13.45x
    • Pre-IPO Market Cap: ₹174.79 Cr
    • Price to Book Value: 8.66

    Efficiency Ratios (Mar 2025)

    • Return on Equity (ROE): 99.59%
    • Return on Capital Employed (ROCE): 48.20%
    • EBITDA Margin: 39.83%
    • Debt to Equity: 1.02

    Objectives of the Issue

    Transparency regarding fund utilization is a hallmark of a fundamentally sound IPO. Bio Medica intends to deploy the net proceeds (approx. ₹35.00 Cr from the fresh issue) toward the following pivotal objectives:

    • Capacity Expansion (₹28.50 Cr): Setting up a brand-new manufacturing facility within their existing premises to scale up production capabilities.
    • Debt Reduction (₹6.50 Cr): Repayment of existing loans, which will immediately improve the balance sheet and reduce finance costs.
    • General Corporate Purposes: Funding day-to-day operational needs and strategic initiatives.

    Promoter Holding & Issue Reservation

    The company is steered by experienced promoters, Mr. Mukesh Mehta and Mr. Pradeep Mehta. Prior to the IPO, they hold a commanding 99.99% stake in the company. Post-issue dilution will bring public shareholders on board, aiding in corporate governance and wealth distribution.

    Investor CategoryReservation AllocationNumber of Shares
    Retail Individual Investors (RII)50.01%17,92,000
    Non-Institutional Investors (HNI)48.98%17,55,000
    Qualified Institutional Buyers (QIB)1.00%36,000
    Market MakerFirm Reservation1,89,000

    SWOT Analysis of Bio Medica Laboratories

    Before applying, it is prudent to weigh the internal and external factors affecting the business through a SWOT perspective:

    Strengths

    • Diversified product portfolio of over 70 injectables.
    • GMP & GLP certified manufacturing facilities.
    • Exceptional surge in ROE and PAT in recent fiscal years.

    Weaknesses

    • High dependence on the B2B contract manufacturing model.
    • Recent spike in total borrowings (pre-IPO).

    Opportunities

    • Proceeds will fund a new facility, drastically increasing production volume.
    • Growing domestic and global demand for generic and OTC parenterals.

    Threats

    • Intensely competitive and fragmented SME pharma sector.
    • Stringent regulatory shifts from health authorities (FDA).

    Market Consensus & Verdict

    Bio Medica Laboratories is operating within a highly competitive segment of contract pharma manufacturing. However, the sheer leap in their top-line and bottom-line numbers between FY23 and FY25 cannot be ignored. The asking price reflects these aggressive growth metrics, meaning the IPO appears fully priced.

    General market sentiment suggests that while the fundamentals look promising due to the planned capacity expansion and debt repayment, investors should approach this with a medium-to-long-term horizon. Risk-tolerant investors looking to diversify into the SME healthcare space might find this an interesting proposition.

    Important Contact & Registrar Details

    For any queries related to allotment, refund status, or application tracking, investors must contact the official registrar to the issue.

    Registrar Info

    Skyline Financial Services Pvt.Ltd.
    Phone: 022-28511022
    Email: ipo@skylinerta.com

    Company Contact

    Bio Medica Laboratories Ltd.
    Plot No. 11B-11C, Sector-E, Sanwer Road
    Industrial Area, Indore, MP – 452015
    Email: companysecretary@biomedica.co.in

    Lead Manager

    Narnolia Financial Services Ltd.

    Disclaimer: The information provided in this blog is for educational and informational purposes only. It does not constitute financial advice. Investing in SME IPOs carries inherent risks. Please consult with a certified financial advisor before making any investment decisions.

  • Q-Line Biotech

    Q-Line Biotech IPO: Comprehensive Analysis, Dates & Financial Overview
    PL
    Publiclisting.in

    Q-Line Biotech IPO: Comprehensive Guide, Dates, Financials & Complete Analysis

    The healthcare and diagnostics sector is experiencing massive transformations, and catching the wave early through public markets can often present intriguing opportunities. The upcoming Q-Line Biotech IPO has been gaining notable attention among retail and institutional market participants alike. In this comprehensive post, we will dissect the company’s core operations, structural offering details, financial health, and strategic objectives to help you make an informed decision.

    Overview: What Does Q-Line Biotech Do?

    Established in the year 2010, Q-Line Biotech Ltd. has built a robust footprint in the healthcare diagnostic arena. The enterprise is primarily engaged in the research, manufacturing, marketing, and distribution of an extensive range of medical diagnostic equipment and consumables.

    • Core Manufacturing: Indigenous production of reagents, spanning Clinical Chemistry, Haematology, Immunodiagnostics, and Molecular Diagnostics.
    • Equipment Supply: Distribution and importing of in-vitro diagnostics (IVD) and pathology devices catering directly to hospitals, medical colleges, and diagnostic centers.
    • Capacity & Scale: As of the latest operational reports, the company boasts an impressive annual capacity of nearly 1.4 million testing kits (including Rapid/Elisa) and 1,200 Selectra machines.
    • Workforce: A dedicated team of 126 in-house employees supported by over 200 third-party workers, working in synergy with an active R&D division.

    Q-Line Biotech IPO Important Dates & Schedule

    Keeping track of public issue timelines is crucial for a smooth application process. Below is the mapped-out schedule for the Q-Line Biotech IPO, from the opening of the bidding window to its eventual listing on the stock exchange.

    May 21, 2026 Issue Opens
    May 25, 2026 Issue Closes
    May 26, 2026 Basis of Allotment
    May 27, 2026 Refunds & Demat Credit
    May 29, 2026 Listing Date
    EventTentative Date
    IPO Open DateThursday, May 21, 2026
    IPO Close DateMonday, May 25, 2026
    Finalization of AllotmentTuesday, May 26, 2026
    Initiation of RefundsWednesday, May 27, 2026
    Credit of Shares to DematWednesday, May 27, 2026
    Listing on NSE SMEFriday, May 29, 2026

    Structural Details & Pricing Breakdown

    The company aims to raise capital via a completely fresh issue mechanism, meaning the funds will be directed entirely to the company rather than early investors cashing out.

    SpecificationDetails
    Issue TypeBook Built Issue
    Total Issue Size₹214.48 Crores (62.53 Lakh Shares)
    Face Value₹10 per equity share
    Price Band₹326 to ₹343 per share
    Listing ExchangeNSE SME
    Offer Type100% Fresh Issue

    Investor Allocation Details

    A well-structured distribution across different categories of market participants ensures wider market participation and stability upon listing.

    • Qualified Institutional Buyers (QIB): 49.99% of the net issue.
    • Non-Institutional Investors (NII/HNI): 15.01% of the net issue.
    • Retail Individual Investors (RII): 35.00% of the net issue.
    • Market Maker Reservation: 5.01% (Approx. 3.13 lakh shares).

    Lot Size & Minimum Investment Requirements

    To participate in this public offering, applicants must bid in lots. The designated base lot size dictates the minimum entry barrier for a retail investor.

    Note for Retail Investors: According to the provided offering data, the minimum required application for a retail investor starts at 2 lots (800 shares), which corresponds to a minimum capital layout of ₹2,74,400 at the upper price band.
    Investor CategoryMinimum LotsTotal SharesInvestment Amount (at Upper Price)
    Retail (Minimum)2 Lots800₹2,74,400
    Retail (Maximum)2 Lots800₹2,74,400
    Small HNI (Minimum)3 Lots1,200₹4,11,600
    Small HNI (Maximum)7 Lots2,800₹9,60,400
    Big HNI (Minimum)8 Lots3,200₹10,97,600

    Financial Performance Overview

    Analyzing historical financial metrics provides deep insight into a company’s operational trajectory. The figures below showcase a restated consolidated view of the company’s financial standing over the past few years.

    Financial Metric (₹ in Crores)Period Ended Dec 31, 2025FY March 31, 2025FY March 31, 2024FY March 31, 2023
    Total Assets561.34455.49339.25251.58
    Total Revenue236.50322.58206.45184.81
    Profit After Tax (PAT)38.6928.1334.4432.10
    EBITDA64.2371.3237.6332.98
    Net Worth(-0.04)189.95161.81127.37
    Total Borrowing243.85164.9596.9173.65

    Observation: While assets and total revenue have showcased an upward trajectory generally, there has been a notable increase in total borrowings in the recent period. It is always wise to compare revenue generation against expanding debt liabilities.

    Key Performance Indicators (KPIs)

    Financial ratios help in benchmarking the valuation and operational efficiency of the business before its public debut.

    KPI MetricDec 31, 2025Mar 31, 2025
    Return on Equity (ROE)16.88%17.66%
    Return on Capital Employed (ROCE)13.32%23.74%
    Debt to Equity Ratio1.060.87
    PAT Margin16.65%8.97%
    EBITDA Margin27.64%22.73%

    Objectives of the Public Issue

    Capital raised through this fresh issue will be injected directly into the company’s structural ecosystem. The management has outlined clear strategic goals for the utilization of the estimated ₹183.50 Crores in net proceeds.

    Allocation PurposeEstimated Amount (₹ in Crores)
    Meeting Working Capital Requirements93.50
    Repayment of Certain Borrowings (Part/Full)90.00
    General Corporate PurposesSubject to finalization
    Total Estimated Utilization183.50

    Promoter Details & Shareholding Pattern

    The core leadership driving Q-Line Biotech includes Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty, and Abhay Agrawal. Consistent founder involvement is often seen as a pillar of long-term strategic execution.

    • Pre-Issue Promoter Holding: 96.77%
    • Post-Issue Holding: Will be diluted following the allocation of 62.53 lakh fresh shares to the public.

    SWOT Analysis of Q-Line Biotech

    Evaluating the holistic business environment is crucial for understanding potential market positioning post-listing:

    • Strengths: The company commands established manufacturing capabilities with a strong emphasis on reverse engineering, R&D, and quality control. Its diversified in-vitro diagnostics (IVD) portfolio and a geographically widespread distribution network fortify long-standing customer relationships.
    • Weaknesses: Rising total borrowings (Debt/Equity over 1.0) could strain free cash flows if interest coverage fluctuates. Furthermore, reliance on a vast number of third-party workers introduces variable dependencies.
    • Opportunities: The post-pandemic surge in healthcare awareness presents significant tailwinds. The planned reduction of debt through IPO proceeds will likely improve future profit margins and balance sheet strength.
    • Threats: The medical diagnostic space is fiercely competitive and highly regulated. Any adverse shifts in health compliance laws or aggressive pricing from larger market players could pose challenges.

    Registrar & Contact Information

    For any direct grievances, allotment status queries, or corporate inquiries, investors can reach out to the official registrar and the company via the following details:

    Registrar to the Issue: Purva Sharegistry (India) Pvt.Ltd.
    Email: support@purvashare.com

    Company Address: Q-Line Biotech Ltd., 298-281, Transport Nagar, Kanpur Road (Adjacent Metro Station), Lucknow, Uttar Pradesh – 226012.
    Compliance Email: compliance@qlinebiotech.com

    Lead Managers representing the issue are Hem Securities Ltd. and Share India Capital Services Pvt.Ltd.

    Conclusion

    The Q-Line Biotech IPO represents an avenue to participate in India’s expanding healthcare and diagnostics ecosystem. The company demonstrates a well-diversified product line and solid manufacturing capacities. The primary objective to drastically reduce debt obligations using the public funds could clear a path for healthier balance sheets and unhindered future growth. However, as is the case with all market-linked instruments, potential participants should rigorously align these operational metrics with their personal risk appetite before making financial commitments.

  • M R Maniveni Foods

    M R Maniveni Foods IPO: Complete Guide, Details, Dates, and Analysis

    M R Maniveni Foods IPO: Complete Guide, Details, Dates, and In-Depth Analysis

    Welcome to Publiclisting.in! The SME public offering space is buzzing with activity, and the upcoming M R Maniveni Foods IPO has captured the attention of market participants. Operating in the essential food processing industry, the company is preparing to enter the public market to fuel its next phase of manufacturing expansion.

    Whether you are considering adding this stock to your portfolio or simply tracking market trends, understanding the fundamentals of the business is crucial. In this comprehensive guide, we will break down the company’s business operations, critical offering dates, financial health, and evaluate the potential risks and rewards through a detailed SWOT analysis.

    Business Overview: What Does M R Maniveni Foods Do?

    Incorporated over a decade ago in June 2010, M R Maniveni Foods Ltd. operates in the highly crucial agricultural and food processing sector. The company specializes in the processing, packaging, and distribution of essential food commodities, specifically focusing on Urad Dal and Toor Dal.

    With a core commitment to delivering quality, safe, and hygienically prepared food, the brand relies on modern processing machinery and robust supply chain practices. Their primary clientele currently sits within the B2B (Business-to-Business) segment, ensuring a consistent volume-based operational flow. Armed with a compact team of 18 employees (as of July 2025), their long-term vision is directed towards creating strong brand recognition across both domestic and international borders.

    Primary Offering Specifications

    Before committing capital, investors need clarity on the size, structure, and pricing of the offering. The company is raising entirely fresh capital through a book-built issue framework on the BSE SME platform.

    ParameterOffering Details
    Issue TypeBookbuilding IPO
    Total Issue Size₹27.04 Crores (52,00,000 equity shares)
    Offer Structure100% Fresh Issue (No Offer for Sale)
    Price Band₹51 to ₹52 per share
    Face Value₹10 per share
    Listing ExchangeBSE SME
    Market Maker Reservation2,60,000 shares (₹1.00 Cr)

    Critical Dates and Timeline

    Timing is everything in the stock market. Below is the detailed sequence of events for this SME offering. Mark these dates on your calendar to ensure you don’t miss the bidding window or the allotment updates.

    Issue Opens
    May 22, 2026
    Issue Closes
    May 26, 2026
    Basis of Allotment
    May 27, 2026
    Refunds/Credit
    May 29, 2026
    Listing Date
    Jun 1, 2026

    Investment Requirements and Lot Sizes

    SME offerings operate differently than mainboard public issues, particularly regarding minimum investment thresholds. Retail and High Net-worth Individuals (HNIs) must apply in predefined lot sizes.

    Investor CategoryMinimum LotsTotal SharesInvestment Amount (at ₹52)
    Retail Individual (Min/Max)1 Lot4,000 Shares₹2,08,000
    Small HNI (Min)3 Lots6,000 Shares₹3,12,000
    Small HNI (Max)9 Lots18,000 Shares₹9,36,000
    Big HNI (Min)10 Lots20,000 Shares₹10,40,000

    Note on Category Reservations: The offering has reserved a maximum of 50% for Qualified Institutional Buyers (QIBs), a minimum of 35% for Retail Investors, and a minimum of 15% for Non-Institutional Investors (NIIs).

    Financial Health and Performance Metrics

    A closer look at the financial books reveals a strong top-line growth trajectory over the past three fiscal years. Let’s analyze how the company has managed its assets, revenues, and profitability.

    Financial Parameter (₹ in Crores)FY 2025 (Mar 31)FY 2024 (Mar 31)FY 2023 (Mar 31)
    Total Assets40.4428.5724.80
    Total Income (Revenue)203.52155.00119.61
    Profit After Tax (PAT)3.882.201.52
    EBITDA7.825.053.72
    Net Worth18.3312.3510.15
    Total Borrowings20.4615.009.93

    Key Performance Indicators (As of FY25)

    • Return on Equity (ROE): 25.27%
    • Return on Capital Employed (ROCE): 18.63%
    • Debt-to-Equity Ratio: 1.12
    • PAT Margin: 1.90%
    • Price to Book Value (P/B): 4.02

    Purpose of Capital Raise (Objectives)

    It is generally a positive indicator when a company utilizes public funds for core expansion rather than cashing out existing promoters. M R Maniveni Foods plans to deploy the net proceeds for the following structural objectives:

    • ₹12.69 Crores: Capital expenditure for the construction of a new factory to scale operations.
    • ₹14.74 Crores: Procurement and installation of modern plant and machinery.
    • Remaining Funds: Allocated towards general corporate purposes to support day-to-day operations and contingencies.

    Management and Shareholding

    The strategic direction of the company is spearheaded by its core promoters: K R Manikandan, M Chandra, and K Selvam. Prior to the public offering, the promoters hold an overwhelming 98.68% stake in the company. After the fresh issue of 5.2 million shares is deployed, this stake will be appropriately diluted, though the exact post-issue holding percentage will depend on the final allotment structure.

    SWOT Analysis of M R Maniveni Foods

    Evaluating the internal and external factors is crucial for understanding the risk-reward ratio of this investment.

    Strengths

    • Over a decade of established presence in the pulses and food commodity industry.
    • Clear B2B client base ensuring steady operational flow.
    • Healthy top-line revenue growth, scaling from ₹119 Cr in FY23 to ₹203 Cr in FY25.

    Weaknesses

    • Low Profit After Tax (PAT) margins standing at just 1.90%, which is typical for trading/processing but limits safety nets.
    • Increasing total borrowings, leading to a moderately high Debt-to-Equity ratio of 1.12.
    • Very small direct employee base (18 members) managing large volumes, which may cause operational bottlenecks.

    Opportunities

    • The proposed ₹27 Cr capital injection is heavily focused on infrastructure (factory and machinery), which can drastically improve production efficiency and margins.
    • Growing demand for hygienically packaged food in both rural and urban domestic sectors.
    • Potential to shift focus towards B2C distribution for higher profit margins in the future.

    Threats

    • The food processing and agricultural commodity market is highly fragmented and fiercely competitive.
    • Vulnerability to raw material price fluctuations caused by uncontrollable factors like weather, crop yield, and government policies.
    • Strict and changing regulatory compliances related to food safety standards.

    Intermediaries and Contact Information

    If you need to reach out regarding allotment status or company queries, here are the official details:

    • Lead Manager: Capital Square Advisors Private Limited
    • Official Registrar: Bigshare Services Private Limited
    • Company Address: S.No.220/3A-3B, Madhavaram-Redhills High Road (Near Vadaperumbakkam), Madhavaram, Chennai, Tamil Nadu – 600060

    Final Thoughts

    The M R Maniveni Foods public offering presents an interesting opportunity to invest in a company that is actively trying to transition from a mid-sized processing unit to a larger scale manufacturing setup. The revenue growth is undeniably impressive, but investors must weigh this against the razor-thin profit margins and the inherent risks of the agricultural commodity market. The decision to invest should align with your personal risk tolerance and portfolio strategy within the SME space.

    Disclaimer: The information provided in this article is for educational and informational purposes only. It does not constitute financial advice. Always consult with a certified financial advisor before making any investment decisions.

  • Autofurnish

    Upcoming Autofurnish SME IPO: Complete Analysis, Financials & Dates
    Premium Market Insights

    A Comprehensive Guide to the Autofurnish SME IPO: Should You Invest?

    The Indian automotive accessory market is witnessing substantial growth, driven by an increasing number of vehicle owners who prefer personalizing and protecting their investments. Capitalizing on this trend is Autofurnish Ltd., a prominent player in the automotive accessories domain. The company is now preparing to enter the public market with its upcoming SME Initial Public Offering (IPO).

    If you are exploring new investment opportunities in the SME segment, this detailed analysis will provide you with all the vital information, from business fundamentals and financial health to critical timelines and valuation metrics, helping you make a well-informed decision.

    Business Overview: What Does Autofurnish Do?

    Incorporated in May 2015, Autofurnish Ltd. specializes in the manufacturing, designing, and trading of automotive accessories. They have built a strong market presence catering to both two-wheelers and four-wheelers. The company strategically operates across two primary business models:

    • B2B Segment: Focused on manufacturing and distributing utility products like car body covers and premium foot mats under their established brands, “Autofurnish” and “Mototrance”.
    • B2C Segment: Operated via their subsidiary, Golden Mace Private Limited, the company directly reaches end consumers through major e-commerce platforms like Amazon, Flipkart, Zepto, and their proprietary website.

    Quality and safety are core pillars of their manufacturing process. Their production facilities boast an impressive lineup of certifications, including ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, IATF 16949:2016, and GMP compliance. Alongside car accessories, they manufacture durable motorcycle gear, riding accessories, polishing pads, and towel cloths.

    Key Highlights of the Public Offering

    The company is launching a Fixed Price Issue to raise approximately ₹15 Crores. The issue entirely consists of fresh equity shares, with no Offer for Sale (OFS) component, meaning all raised funds will be directed back into the company’s growth initiatives.

    ParticularsDetails
    Issue TypeFixed Price SME IPO
    Total Issue Size35,61,000 Shares (Aggregating ~₹15.00 Cr)
    Fresh Issue Size33,81,000 Shares (~₹14.00 Cr)
    Market Maker Portion1,80,000 Shares (~₹0.73 Cr)
    Issue Price₹41 per equity share
    Face Value₹10 per share
    Listing PlatformBSE SME

    Crucial Dates & Application Schedule

    Timing is everything in the stock market. Below is the complete schedule for the offering. Make sure to mark these dates on your calendar if you plan to bid.

    1
    Issue Opens
    May 21, 2026
    2
    Issue Closes
    May 25, 2026
    3
    Basis of Allotment
    May 26, 2026
    4
    Refunds/Credit
    May 27, 2026
    5
    Listing Date
    May 29, 2026
    EventTentative DateDay of the Week
    Bid/Offer OpeningMay 21, 2026Thursday
    Bid/Offer ClosingMay 25, 2026Monday
    Finalization of AllotmentMay 26, 2026Tuesday
    Initiation of Refunds & Demat CreditMay 27, 2026Wednesday
    Listing on BSE SMEMay 29, 2026Friday

    Minimum Investment Breakdown & Lot Size

    In SME IPOs, trading occurs in standardized lot sizes rather than single shares. For this specific offering, an application requires a base of multiple lots. Below is the investment structure required for different investor categories:

    Investor CategoryMinimum LotsTotal SharesInvestment Amount (₹)
    Retail Individual Investors (Min)2 Lots6,000₹2,46,000
    Retail Individual Investors (Max)2 Lots6,000₹2,46,000
    High Net-Worth Individuals (HNI)3 Lots9,000₹3,69,000

    Note: The standard lot size is 3,000 shares, but the minimum application size mandates at least 2 lots for retail participants.

    Financial Health & Growth Metrics

    Evaluating a company’s financial track record is critical before investing. A steady increase in revenue and consistent profitability are generally positive indicators. Here is a look at the restated consolidated financials over the last few fiscal years (Values in ₹ Crore).

    Financial MetricFY 2023 (Mar 31)FY 2024 (Mar 31)FY 2025 (Mar 31)Period End (Dec 31, 2025)
    Total Assets14.1116.0123.2833.50
    Total Revenue10.6015.9233.8828.32
    EBITDA0.852.825.114.79
    Profit After Tax (PAT)0.161.633.502.83
    Net Worth7.509.0714.7117.57
    Financial Observation: The company has displayed aggressive growth, with revenue more than doubling from FY24 (₹15.92 Cr) to FY25 (₹33.88 Cr). Consequently, the Profit After Tax (PAT) has also seen a significant leap, reflecting improved operational efficiency.

    Valuation & Performance Indicators

    Understanding how the issue is priced relative to its earnings can help gauge whether the stock is fairly valued. Based on the latest available financial data, here are the Key Performance Indicators (KPIs):

    Key MetricValue (As of Mar 31, 2025)
    Return on Equity (ROE)23.50%
    Return on Capital Employed (ROCE)33.74%
    Debt to Equity Ratio0.36
    PAT Margin10.51%
    Pre-IPO EPS₹3.52
    Post-IPO P/E Ratio (Approx)14.7x

    Fund Utilization Plan: Where is the Money Going?

    The total capital raised via this fresh issue is estimated to be utilized strategically to fuel further expansion. The estimated breakdown of the fund allocation is as follows:

    • Working Capital Requirements: ₹9.50 Crores to ensure smooth day-to-day operations and inventory management.
    • General Corporate Purposes: ₹1.96 Crores allocated for broader company-level strategic initiatives.
    • Capital Expenditure (Machinery): ₹1.89 Crores to purchase new manufacturing equipment, boosting production capacity.
    • Issue Management Expenses: ₹1.45 Crores to cover the legal, regulatory, and marketing costs associated with the IPO.

    Ownership Structure & Promoters

    The driving force behind the company includes Mr. Puneet Arora and Mr. Ruppal Wadhwa. A high promoter holding typically indicates strong faith by the founders in their business model.

    Holding StagePromoter Stake (%)
    Pre-Issue Holding93.10%
    Post-Issue Holding68.57%

    Post-listing, the promoters will continue to retain a commanding majority stake of 68.57%, ensuring their interests remain aligned with long-term shareholder value.

    SWOT Analysis of the Company

    To provide a balanced perspective, here is a quick SWOT analysis of the company’s business positioning:

    • Strengths: A highly diversified product portfolio under one roof, extensive ISO and GMP certifications guaranteeing product quality, and a robust dual approach covering both B2B and B2C markets.
    • Weaknesses: High reliance on third-party e-commerce platforms (like Amazon and Flipkart) for retail sales, which subjects them to changing platform algorithms and commission structures.
    • Opportunities: The rapidly expanding domestic automotive sector and a booming EV market provide a massive runway for customized automotive accessories.
    • Threats: The auto accessories market is heavily fragmented with intense competition from unorganized local players and price volatility in raw materials like rubber and textiles.

    Key Intermediaries & Contact Information

    For investors requiring further assistance or those who need to address grievances post-allotment, the following registered entities are managing the issue:

    • Lead Manager: Novus Capital Advisors Pvt. Ltd.
    • Registrar to the Issue: Skyline Financial Services Pvt. Ltd.
    • Market Maker: NDA Securities Ltd.

    Company Contact Details

    Autofurnish Ltd.
    K-55, Udyog Nagar, Peeragarhi,
    Nangloi West Delhi, New Delhi, 110041
    Email: corporate@autofurnish.com

    Final Thoughts

    The SME public offering by Autofurnish brings forward an interesting proposition within the automotive ancillary space. Backed by solid revenue growth over the last three years and a healthy Return on Capital Employed (ROCE) of over 33%, the business exhibits strong fundamental momentum. Furthermore, utilizing a significant portion of the IPO proceeds for capacity expansion and working capital paints a forward-looking picture.

    As is standard with all SME listings, the larger lot size involves higher capital deployment and potentially different liquidity dynamics compared to mainboard listings. Investors should weigh the company’s growth trajectory against the broader market conditions and their individual risk appetite before participating.

  • Harikanta Overseas

    Harikanta Overseas IPO Analysis, Dates, Price Band & Financials | Publiclisting.in

    Publiclisting.in

    Your Trusted Partner for Financial & IPO Insights

    Harikanta Overseas IPO: Complete Analysis, Financials, and Investment Guide

    Welcome to Publiclisting.in! The Indian SME market is buzzing with fresh opportunities, and the latest entrant seeking to capture investor attention is Harikanta Overseas Ltd. With the textile industry acting as a backbone for India’s growing export economy, this manufacturing company is stepping into the public market to fund its next phase of growth.

    In this comprehensive guide, we will break down everything you need to know about the Harikanta Overseas IPO. From crucial dates and lot sizes to an in-depth look at their financial health and future objectives, our goal is to provide you with clear, unbiased, and highly informative data so you can navigate this investment opportunity with confidence.

    Business Overview: What Does Harikanta Overseas Do?

    Incorporated in 2018, Harikanta Overseas Ltd. operates in the highly dynamic sector of synthetic textile fabric manufacturing. Over the years, the company has built a robust product portfolio catering to both domestic and international fashion demands.

    • Core Products: The company specializes in manufacturing Ikat fabrics, polyester garment fabrics, saree materials, dhupion fabrics, poly linen, and natural fiber fabrics.
    • Target Audience: A major portion of their production is dedicated to women’s ethnic wear, including sarees, kurtas, and dress materials. They also produce fabrics for men’s traditional wear.
    • Infrastructure: Their state-of-the-art manufacturing unit is strategically located in Surat, Gujarat—the textile hub of India—spreading across nearly 954 sq. meters.
    • Market Reach: Domestically, they have a strong footprint in Delhi, Karnataka, Maharashtra, UP, Punjab, and Rajasthan. Internationally, they export to markets like Singapore, Bahrain, and Thailand.

    Harikanta Overseas IPO Specifications

    Before committing your capital, it is essential to understand the structure of the IPO. This issue is an entirely fresh issue, meaning all the funds raised will go directly to the company rather than existing promoters selling their stakes.

    IPO AttributeDetails
    Issue TypeBook Built Issue (SME)
    Total Issue Size₹25.63 Crores (26.70 Lakh Shares)
    Price Band₹91 to ₹96 per equity share
    Face Value₹10 per share
    Listing PlatformBSE SME
    Retail AllocationApprox. 48.94% of the net issue
    NII (HNI) AllocationApprox. 48.94% of the net issue
    QIB AllocationApprox. 2.13% of the net issue

    Important IPO Dates (Schedule Tracker)

    Timing is everything in the stock market. Below is the tentative schedule for the IPO process. Make sure to mark these dates on your calendar if you plan to bid.

    IPO Opens

    May 20, 2026

    IPO Closes

    May 22, 2026

    Allotment Status

    May 25, 2026

    Refunds / Demat Credit

    May 26, 2026

    Listing Date

    May 27, 2026

    Minimum Investment & Lot Size Breakdown

    Unlike mainboard IPOs, SME IPOs have larger lot sizes and require a higher initial capital commitment. The minimum lot size for a retail investor is mapped out below.

    Note: For Retail Investors, the minimum application size defined for this IPO is 2 Lots (2,400 shares), which amounts to a minimum investment of ₹2,30,400 at the upper price band.

    Investor CategoryMinimum LotsTotal SharesInvestment Amount (at ₹96)
    Retail Individual Investor2 Lots2,400₹2,30,400
    Small HNI (S-HNI) Min3 Lots3,600₹3,45,600
    Small HNI (S-HNI) Max8 Lots9,600₹9,21,600
    Big HNI (B-HNI) Min9 Lots10,800₹10,36,800

    Why is Harikanta Overseas Raising Capital?

    A fundamental check for any IPO is understanding how the company intends to utilize the raised funds. Harikanta Overseas has clearly outlined its capital allocation strategy, which focuses heavily on scaling its manufacturing capacity:

    • Machinery Purchase (₹9.33 Cr): A major chunk of the proceeds will be utilized to upgrade and expand their manufacturing machinery, enhancing production volume and efficiency.
    • Factory Premises (₹5.40 Cr): Funding capital expenditure for expanding their physical infrastructure.
    • Working Capital (₹4.75 Cr): To ensure smooth day-to-day operations and manage the supply chain efficiently.
    • General Corporate Purposes: Remaining funds will be deployed for broad operational initiatives.

    Financial Health & Performance Metrics

    Financial stability is the most critical metric for long-term investors. We have evaluated the restated consolidated financial numbers to give you a clear picture of the company’s trajectory.

    Financial MetricPeriod Ended Nov 30, 2025 (₹ in Cr)Period Ended Mar 31, 2025 (₹ in Cr)
    Total Assets32.5123.12
    Total Revenue26.2835.50
    EBITDA7.356.72
    Profit After Tax (PAT)5.094.47
    Net Worth18.7713.79
    Total Borrowings2.873.26

    Key Performance Indicators (KPIs) & Valuation Insights

    • EBITDA Margin: Impressive growth observed, standing at 27.97% (as of Nov 2025).
    • PAT Margin: Healthy profitability with a 19.50% margin.
    • Return on Capital Employed (ROCE): A solid 31.99%, indicating efficient use of capital.
    • Debt-to-Equity Ratio: Maintained at a very low 0.15, signaling minimal leverage risk.
    • Valuation (P/E Ratio): The Pre-IPO P/E ratio is estimated at 15.46x, settling around 12.42x post-IPO.

    Promoter Background & Shareholding Structure

    The company is led by a capable management team comprising Hardik Gotawala, Abhishek Gotawala, and Nilesh Gotawala. The strength of promoter holding acts as a confidence booster for retail participants.

    Shareholding PhasePromoter Stake (%)
    Pre-Issue Shareholding96.87%
    Post-Issue Shareholding70.66%

    Strategic SWOT Analysis

    To provide a well-rounded perspective, here is an objective evaluation of the company’s internal and external market positioning.

    Strengths

    Diverse product range targeting high-demand segments (women’s ethnic wear). Established export footprint and strong presence in the domestic textile hub (Surat).

    Weaknesses

    Textile manufacturing is highly working-capital intensive. The business relies heavily on the steady supply of synthetic raw materials.

    Opportunities

    The proposed capital expenditure will expand machinery and scale up production, allowing the company to tap into broader global markets.

    Threats

    The SME textile segment is highly fragmented and competitive. Unpredictable shifts in fashion trends and fluctuating raw material costs pose constant risks.

    Registrar and Lead Manager Details

    For inquiries regarding allotment status, application forms, or refund processing, investors can reach out directly to the official registrar of the issue.

    • Registrar of the Issue: Bigshare Services Pvt. Ltd. (Email: ipo@bigshareonline.com)
    • Book Running Lead Manager: Interactive Financial Services Ltd.
    • Market Maker: Aftertrade Broking Pvt. Ltd.
    • Company Contact: info@harikantaoverseas.com

    Final Thoughts

    The Harikanta Overseas IPO presents an opportunity to invest in a growing entity within India’s robust textile sector. With a solid expansion plan mapped out through their capital expenditure objectives, low debt levels, and healthy EBITDA margins, the company appears positioned to scale its operations. However, the relatively high minimum investment threshold typical of SME IPOs requires investors to carefully weigh their risk appetite against the highly competitive nature of the garment industry.

    As always, thorough research and portfolio alignment are key to successful investing. Keep a close watch on the subscription numbers starting May 20, 2026, to gauge broader market interest.

    Thank you for reading this analysis on Publiclisting.in. Stay tuned for more deep dives into upcoming IPOs, market trends, and financial strategies!

  • Vegorama Punjabi Angithi

    Vegorama Punjabi Angithi IPO: Complete Guide, Dates, Financials & Analysis | Publiclisting.in

    Publiclisting.in

    Your Trusted Source for Independent IPO Analysis & Market Trends

    Vegorama Punjabi Angithi IPO: Complete Guide, Dates, Financials & Comprehensive Analysis

    Welcome back to Publiclisting.in! The Indian primary market continues to buzz with exciting opportunities, and the upcoming Vegorama Punjabi Angithi IPO is drawing significant attention from investors. Slated to hit the BSE SME board in May 2026, this quick-service restaurant (QSR) chain is looking to raise funds for its next phase of aggressive expansion.

    If you are considering adding this SME IPO to your investment portfolio, it is crucial to understand the company’s business model, financial trajectory, valuation, and fundamental strengths. Let’s dive into an in-depth, data-backed review of the Vegorama Punjabi Angithi IPO.

    Business Model: What Does Vegorama Punjabi Angithi Do?

    Established in early 2022, Vegorama Punjabi Angithi Limited has rapidly carved a niche for itself in the vibrant food and beverage (F&B) sector. Operating under the popular brand name “Punjabi Angithi”, the company serves authentic, affordable, and high-quality vegetarian North Indian cuisine.

    The company operates via a highly scalable, multi-format business model:

    • Cloud Kitchens: The backbone of their delivery network, operating 19 dedicated cloud kitchens across the Delhi NCR region (ranging from 400 to 870 sq. ft.).
    • Fine-Dining & QSR: Operating two premium fine-dining spaces (spanning around 2,400 sq. ft.) alongside quick-service dine-in setups.
    • Online Food Delivery: Seamless integration with top food aggregators like Zomato and Swiggy, supplemented by their own in-house delivery fleet.
    • Catering Services: Providing bulk food services for corporate events, parties, and private gatherings.

    Core IPO Details

    The company is launching a Book Built Issue to raise a total of ₹38.38 Crores. This includes a fresh issue of shares alongside a minor Offer For Sale (OFS) by the promoters. Below is a snapshot of the essential structural details of the offering:

    ParameterDetails
    IPO Open DateMay 20, 2026
    IPO Close DateMay 22, 2026
    Face Value₹10 per share
    Price Band₹73 to ₹77 per share
    Total Issue Size49,84,000 shares (₹38.38 Cr)
    Fresh Issue Size37,36,000 shares (₹30.70 Cr)
    Offer for Sale (OFS)9,96,800 shares (₹7.68 Cr)
    Listing ExchangeBSE SME

    IPO Timeline & Critical Dates

    Missing a deadline can mean missing out on a potential listing gain. Track the progress of the Vegorama Punjabi Angithi IPO using the timeline below:

    1

    Bidding Opens

    May 20, 2026

    2

    Bidding Closes

    May 22, 2026

    3

    Basis of Allotment

    May 25, 2026

    4

    Refunds / Demat Credit

    May 26, 2026

    5

    Listing on BSE SME

    May 27, 2026

    Investment Requirements: Lot Size Breakdown

    For SME IPOs, retail investors cannot apply for single shares; they must apply in designated lot sizes. The price band upper limit of ₹77 dictates the minimum investment amount.

    Investor CategoryMinimum LotsTotal SharesInvestment Amount (at ₹77)
    Retail (Min)2 Lots3,200₹2,46,400
    Retail (Max)2 Lots3,200₹2,46,400
    HNI / sNII (Min)3 Lots4,800₹3,69,600
    HNI / bNII (Min)9 Lots14,400₹11,08,800

    Quota Distribution (Net Issue)

    • QIB (Qualified Institutional Buyers): 49.97% (Includes Anchor Investor portion of 28.41%)
    • Retail Individual Investors: 35.02%
    • Non-Institutional Investors (HNI): 15.01%

    Financial Health & Performance Metrics

    A deep dive into the restated financial statements reveals significant growth in both top-line and bottom-line figures over the last three financial cycles. This upward trajectory is a strong indicator of brand acceptance and operational scaling.

    Financial Metric (₹ in Crores)31 Dec 2025 (9 Months)31 Mar 2025 (FY25)31 Mar 2024 (FY24)31 Mar 2023 (FY23)
    Total Assets31.8124.7718.355.59
    Total Revenue105.35102.0666.3716.91
    Profit After Tax (PAT)9.048.224.640.84
    Net Worth23.3714.346.121.47
    Total Borrowing3.625.054.000.23

    Key Performance Indicators (KPIs)

    The operational efficiency of the company can be measured through its robust KPIs. The management has maintained strong margins while significantly reducing its debt-to-equity ratio ahead of the IPO.

    IndicatorValue (As of latest filings)
    EBITDA Margin11.81%
    PAT Margin8.60%
    Return on Equity (ROE)47.93%
    Return on Capital Employed (ROCE)53.73%
    Pre-Issue P/E Ratio11.82x
    Post-Issue P/E Ratio10.61x
    Price to Book Value (P/BV)6.78

    Strategic Objectives: How Will the Funds Be Used?

    Transparency in capital allocation is key to building investor trust. Vegorama Punjabi Angithi intends to utilize the net proceeds of the fresh issue (approx. ₹23.32 Crores after issue expenses) for direct business scaling:

    • ₹11.82 Crores: Allocated towards the construction of new banquets and fine-dining restaurants.
    • ₹4.93 Crores: Dedicated to rolling out new cloud kitchens to deepen market penetration.
    • ₹4.27 Crores: Setting up a state-of-the-art centralized kitchen to standardize taste, improve hygiene, and reduce per-unit production costs.
    • ₹2.30 Crores: Upgrading and modernizing the existing cloud kitchen facilities.
    • Remaining Funds: Directed toward general corporate purposes.

    Comprehensive SWOT Analysis

    Before investing, it is vital to weigh the internal strengths against external market forces. Here is our exclusive SWOT analysis for Vegorama Punjabi Angithi Limited:

    Strengths

    • Strong brand recall in the Delhi NCR region for affordable North Indian/Punjabi cuisine.
    • Asset-light cloud kitchen model minimizes rental overheads and boosts profit margins.
    • Stellar financial track record with revenue jumping from ₹16.91 Cr (FY23) to over ₹105 Cr (Dec FY25).

    Weaknesses

    • Heavy geographical concentration; operations are currently heavily reliant on the Delhi NCR market.
    • High dependence on third-party aggregators (Zomato/Swiggy) which may squeeze margins through high commission rates.

    Opportunities

    • Expansion into Tier-2 cities where the appetite for branded, hygienic QSR food is growing rapidly.
    • The proposed centralized kitchen will bring economies of scale, further boosting the EBITDA margin.
    • Growing trend of online food delivery post-pandemic acts as a continuous tailwind.

    Threats

    • Intense competition from unorganized local eateries and established QSR chains.
    • Vulnerability to inflation in raw material costs (vegetables, dairy, cooking oils).
    • Changing consumer dietary trends moving towards health-conscious/vegan alternatives.

    Promoter Holdings & Leadership

    The company is led by a dedicated management team with deep roots in the F&B industry. The promoters steering the vision are Mr. Deepak Chadha, Mr. Subash Chander Chadha, and Mrs. Teenu Chadha.

    • Pre-Issue Promoter Holding: 99.41%
    • Post-Issue Holding: Will be diluted post-listing, ensuring sufficient public float and market liquidity.

    Contact & Registrar Information

    For allotment status, queries, or further official documentation, investors can reach out to the official registrar of the issue or the company directly.

    Registrar to the Issue: Bigshare Services Pvt. Ltd.
    Phone: +91-22-6263 8200
    Email: ipo@bigshare.com

    Company Address:
    Vegorama Punjabi Angithi Ltd.
    B-376, Third Floor, Meera Bagh, Outer Ring Road, Paschim Vihar, New Delhi – 110063
    Phone: +91-11-46112637
    Email: compliance@punjabiangithi.in

    Lead Manager: Corporate Makers Capital Ltd.

    Final Verdict & Key Takeaways

    The Vegorama Punjabi Angithi IPO presents a compelling case for those looking to invest in the rapidly expanding Indian QSR and cloud kitchen segment. The company has demonstrated phenomenal top-line and bottom-line growth over a short span, successfully transitioning from a nascent startup to a highly profitable entity generating over ₹100 Crores in revenue.

    The strategic deployment of funds toward a centralized kitchen and new geographic rollouts indicates a management focused on long-term scalability. While the SME space inherently carries a degree of volatility and risk, companies with strong fundamentals, clear cash flows, and a recognized consumer brand generally offer solid prospects.

    As always, prospective investors should carefully evaluate their own risk appetite, review the overall market sentiment, and maintain a medium-to-long-term horizon when participating in SME IPOs.

    Disclaimer: The information provided in this article is for educational and analytical purposes only. It does not constitute financial advice. Please consult with a certified financial advisor before making any investment decisions.

  • NFP Sampoorna Foods

    NFP Sampoorna Foods IPO: Complete Analysis & Details – Publiclisting.in
    PublicListing.in

    In-Depth Analysis: NFP Sampoorna Foods SME IPO

    As health-consciousness continues to shape consumer buying habits, the premium dry fruit and nuts sector is witnessing unprecedented growth. Stepping into the spotlight is NFP Sampoorna Foods, an established player in the processing and distribution of high-quality dry fruits, now preparing to launch its Initial Public Offering (IPO) on the NSE SME platform.

    Whether you are a retail investor looking to diversify your portfolio or a High Net-Worth Individual (HNI) eyeing the FMCG space, understanding the fundamentals of an upcoming public issue is crucial. In this comprehensive guide, we break down the core business model, financial health, issue objectives, and valuation metrics of the upcoming NFP Sampoorna Foods IPO.

    Overview of the Business: What Does NFP Sampoorna Foods Do?

    Established in the year 2019, NFP Sampoorna Foods Ltd has swiftly carved a niche for itself in the premium health foods segment, primarily focusing on the processing and trading of dry fruits.

    The company operates an end-to-end business model that begins with the global procurement of raw materials. A significant portion of their raw cashew is imported directly from Africa. By leveraging advanced roasting and packaging technologies, the brand ensures that the nutritional integrity and freshness of the nuts are meticulously preserved.

    Core Product Portfolio:

    • Premium Cashew Nuts: Graded varieties including highly sought-after W320 and W400.
    • Almonds: Sourced from top-tier growers, available in both natural and roasted variants.
    • Makhana (Fox Nuts): Catering to the healthy snacking trend with plain, roasted, and flavored options.
    • Festive & Corporate Gifting: Curated gift hampers that see massive demand during the holiday and festival seasons.

    Quality remains at the forefront of their operations. The company holds esteemed ISO 9001:2015 and ISO 22000:2018 certifications, validating their commitment to strict food safety and quality management. Their products reach consumers through a robust omnichannel distribution network, spanning traditional offline retail to massive e-commerce giants like Amazon, Flipkart, and their proprietary digital storefront.

    NFP Sampoorna Foods IPO: Key Issue Details

    The company is set to raise capital entirely through a fresh issue of shares, signaling intent to utilize funds directly for business scaling rather than providing an exit for existing promoters.

    IPO AttributeDetails
    Issue TypeBook Built Issue (Fresh Capital Only)
    Total Issue Size₹24.53 Crores (44,60,000 Equity Shares)
    Face Value₹10 per share
    Price Band₹52 to ₹55 per share
    Market Lot Size2,000 Shares
    Listing ExchangeNSE SME
    Pre-IPO Market Capitalization₹69.49 Crores

    IPO Schedule & Tracker

    Timing is critical in the primary market. Below is the tentative timeline for the bidding, allotment, and listing phases of the issue.

    May 18, 2026
    Issue Opens
    May 20, 2026
    Issue Closes
    May 21, 2026
    Basis of Allotment
    May 22, 2026
    Refunds & Demat Credit
    May 25, 2026
    Listing Date

    Investment Limits & Lot Sizes

    The allocation is structured to accommodate Retail Individual Investors, Non-Institutional Investors (HNI), and Qualified Institutional Buyers (QIB). Below is the breakdown of minimum and maximum investment requirements.

    Investor CategoryMinimum LotsTotal SharesInvestment Amount (at ₹55)
    Retail Investor (Min/Max)1 Lot2,000 Shares₹1,10,000
    Small HNI (Min)2 Lots4,000 Shares₹2,20,000
    Big HNI (Min)10 Lots20,000 Shares₹1,10,000

    Note: The net offer reserves approximately 49.58% for Retail Investors, 49.43% for HNIs, and 0.99% for QIBs. Market makers are allotted 2,24,000 shares.

    Financial Performance Analysis

    A transparent look at the historical financial data highlights the company’s trajectory in revenue generation, asset accumulation, and profitability.

    Financial Metric (₹ in Crores)FY 2023 (Mar 31)FY 2024 (Mar 31)FY 2025 (Mar 31)FY 2026 (Nov 30)*
    Total Assets8.9016.6827.0344.02
    Total Revenue16.756.0035.7636.96
    Profit After Tax (PAT)0.410.152.673.49
    Net Worth8.546.349.0215.70
    Total Borrowings–8.5311.3624.94

    *Data up to November 30, 2025. The rapid jump in revenue and PAT in FY25 and the partial FY26 points to aggressive market expansion, though matched by a proportional increase in borrowings to fund this growth.

    Key Valuation Metrics (KPIs)

    • Return on Equity (ROE): 28.21% (Robust return on shareholder funds)
    • Return on Capital Employed (ROCE): 24.71%
    • Debt to Equity Ratio: 1.59 (Indicates significant leverage)
    • PAT Margin: 9.46%
    • Pre-IPO P/E Ratio: 16.81x
    • Post-IPO P/E Ratio: 13.28x

    Objectives of the Fresh Issue

    Capital raised from the public markets will be strategically deployed to fortify the balance sheet and enhance operational liquidity.

    • Working Capital Requirements (₹7.25 Cr): To ensure a smooth supply chain, bulk procurement of raw cashews, and inventory management.
    • Debt Reduction (₹9.50 Cr): Prepayment or repayment of outstanding borrowings, which is expected to lower interest costs and improve bottom-line margins.
    • General Corporate Purposes: Utilizing the remaining balance for brand building, talent acquisition, and unforeseen operational needs.

    SWOT Analysis of NFP Sampoorna Foods

    Strengths

    • High-standard ISO certifications ensure product quality and consumer trust.
    • Diverse omnichannel presence across offline and online e-commerce platforms.
    • Experienced promoter group with deep industry relationships.

    Weaknesses

    • Relatively high Debt-to-Equity ratio (1.59) restricting financial flexibility pre-IPO.
    • Heavy reliance on imported raw materials (Africa), exposing them to foreign exchange and logistical risks.

    Opportunities

    • Surging domestic demand for healthy snacking and premium dry fruits.
    • Expanding B2B corporate gifting networks.
    • Potential to penetrate deeper into Tier-2 and Tier-3 cities in India.

    Threats

    • Intense competition from both highly organized FMCG brands and unorganized local players.
    • Volatility in global raw material pricing and fluctuating agricultural yields.

    Promoter Holding & Management

    The company is steered by experienced promoters: Praveen Goel, Anju Goel, and Yash Vardhan Goel. Their extensive background in the agricultural commodity and FMCG sectors provides a solid foundation for the business.

    Prior to the IPO, the promoters held a commanding 99.99% stake in the company. Following the issuance of new shares, this holding will be diluted, inviting public participation into the company’s growth story.

    General Market Viewpoint

    Market observers have noted the company’s consistent growth in top and bottom lines over recent financial periods, reflecting strong market demand for premium dry fruits. The issue appears to be fully priced based on recent earnings multipliers. Investors keeping an eye on this IPO should note recent structural changes, such as the induction of a new market maker and underwriter. Generally, such fully priced issues in highly competitive sectors are viewed as long-term wealth generation plays, making them suitable for cash-surplus investors willing to hold through market volatility.

    Key Contacts & Intermediaries

    Company AddressNFP Sampoorna Foods Ltd.
    Ground Floor B-3A & B-3B, Plot No 70,
    Najafgarh Road Industrial Area, Rama Road,
    New Delhi – 110015
    Company Emailcompliance@sampoornanuts.com
    Lead Manager3Dimension Capital Services Ltd.
    Registrar to the IssueSkyline Financial Services Pvt. Ltd.
    Market MakerAnant Securities

    Conclusion

    The NFP Sampoorna Foods IPO presents an interesting opportunity to invest in India’s booming health foods and dry fruit sector. With solid revenue growth, a clear roadmap to reduce debt via the IPO proceeds, and an established distribution network, the fundamentals look promising. However, prospective investors must weigh these strengths against the inherent risks of a debt-heavy pre-IPO balance sheet and intense sector competition. As always, assessing personal risk appetite and conducting thorough due diligence is advised before subscribing to any SME issue.

  • Teamtech Formwork Solutions

    Teamtech Formwork Solutions IPO: In-Depth Analysis, Dates, and Financials
    P
    Publiclisting.in

    Teamtech Formwork Solutions IPO: Complete Analysis, Subscription Details, and Financial Outlook

    The Indian infrastructure sector is undergoing massive expansion, and with it comes a surging demand for modern construction methodologies. Enter Teamtech Formwork Solutions Ltd., a company preparing to tap into the primary markets through its upcoming SME Initial Public Offering (IPO). This comprehensive guide provides you with essential insights into the company’s business model, valuation metrics, critical timeline dates, and overall investment prospects.

    Business Overview: What Does Teamtech Formwork Solutions Do?

    Established in November 2018, Teamtech Formwork Solutions Limited operates on a dedicated Business-to-Business (B2B) framework. The company specializes in manufacturing, refurbishing, and renting out modular T-formwork systems that are essential for the modern construction industry.

    • Product Portfolio: They offer a comprehensive range of standard panels, customized formwork systems, and specialized supporting accessories tailored to various structural needs.
    • Application Areas: Their engineering solutions are heavily utilized for vertical concrete structures, including shafts, foundations, bridges, commercial walls, circular tanks, and complex foundations.
    • Infrastructure Hub: The company boasts an expansive 20,000 sq. ft. in-house manufacturing and refurbishment facility located in Bollaram, Telangana. This facility integrates advanced laser and plywood cutting machinery alongside top-tier planning software for project estimation.

    Core Details of the Public Issue

    The company is aiming to raise fresh capital from the market through a fully book-built issue. Below are the structural parameters of the offering:

    ParticularsDetails
    IPO Open DateMay 19, 2026
    IPO Close DateMay 21, 2026
    Issue Size₹50.15 Crores (7,960,000 shares)
    Issue Type100% Fresh Issue (Book Built)
    Face Value₹5 per share
    Price Band₹61 to ₹63 per share
    Listing ExchangeNSE SME

    Critical Dates & IPO Timetable

    Staying ahead of crucial deadlines is vital for a smooth application process. The visual timeline below tracks the journey from the issue opening to its grand debut on the stock exchange.

    ✓
    IPO Opens
    May 19, 2026
    2
    IPO Closes
    May 21, 2026
    3
    Allotment Status
    May 22, 2026
    4
    Refunds & Credit
    May 25, 2026
    5
    Listing Date
    May 26, 2026

    Investment Lot Size & Subscription Categories

    The offering is neatly categorized to accommodate various investor classes, including Retail Individual Investors, High Net Worth Individuals (HNIs), and Qualified Institutional Buyers (QIBs).

    Important Application Note: While the base lot size is mathematically 2,000 shares, the official mandate requires retail investors to place a minimum bid of 4,000 shares (2 lots).
    Investor CategoryMinimum LotsTotal SharesInvestment Amount (at Upper Band)
    Retail Investor (Min & Max)2 Lots4,000 Shares₹2,52,000
    Small HNI (Min)3 Lots6,000 Shares₹3,78,000
    Small HNI (Max)7 Lots14,000 Shares₹8,82,000
    Big HNI (Min)8 Lots16,000 Shares₹10,08,000

    Reservation Quota: The net offer restricts reservations to specific limits—QIBs command 49.97% (including anchor portions), Retail takes 35.03%, and Non-Institutional Investors (NII/HNI) are allocated 15.00%. A 5.03% segment is carved out for the Market Maker to ensure post-listing liquidity.

    Financial Health & Valuation Metrics

    A deep dive into the financial statements reveals an aggressive growth trajectory, particularly in the most recent fiscal year.

    Financial Parameter (₹ in Crores)FY 2024FY 2025FY 2026
    Total Assets24.9640.0066.75
    Total Income30.3132.9854.23
    Profit After Tax (PAT)7.697.8411.59
    Net Worth13.7921.6333.22
    Total Borrowing3.6411.1016.68

    Key Performance Indicators (KPIs)

    As of March 31, 2026, the company showcases highly competitive valuation metrics:

    • Return on Equity (ROE): 42.26%
    • Return on Capital Employed (ROCE): 40.92%
    • Debt-to-Equity Ratio: 0.50
    • PAT Margin: 21.60%
    • EBITDA Margin: 32.61%

    Promoters & Objective of the Issue

    The company is spearheaded by visionary promoters: Eldo Varghese, Chaitanya Prakash Kotagiri, and Salinraj Kunnummal. Prior to the IPO, the promoters held a commanding 81.25% stake in the entity.

    The net proceeds generated from the ₹50.15 crore fresh issue will be mobilized for the following strategic objectives:

    • Capital Expenditure: ₹11.92 Crores allocated for purchasing new plant machinery for an upcoming manufacturing unit.
    • Debt Reduction: ₹15.50 Crores earmarked for the repayment or prepayment of existing borrowings, which will improve the balance sheet.
    • Working Capital: ₹13.77 Crores to fuel day-to-day operational requirements.
    • General Corporate Purposes: The balance amount will be utilized for broader business development initiatives.

    SWOT Analysis of Teamtech Formwork Solutions

    Strengths

    The company benefits from a robust B2B model backed by long-standing client relationships. An impressive Return on Equity (over 42%) and an integrated in-house manufacturing process create a solid competitive moat.

    Weaknesses

    General market sentiment observes that the massive spike in revenue and net profit specifically in FY26 raises legitimate questions regarding the long-term sustainability of such high margins. The valuation appears to price in perfect future execution.

    Opportunities

    With India experiencing a rapid infrastructure and real estate boom, the demand for scalable, customized, and modular construction equipment like T-formworks is poised to surge tremendously.

    Threats

    The construction ancillary market is highly fragmented. Intensive competition from unorganized sectors, potential raw material pricing volatility, and macroeconomic shifts in the real estate sector remain ongoing threats.

    Key Contact & Intermediary Information

    For application-related queries or company communication, investors can refer to the following official channels:

    • Registrar to the Issue: Kfin Technologies Ltd. (Contact: 040-67162222 / teamtech.ipo@kfintech.com)
    • Lead Manager: GetFive Advisors Pvt. Ltd.
    • Market Maker: SMC Global Securities Ltd.
    • Company Registered Office: 3rd Floor, Plot No. 1050/1, Sree Sai Enclave, Hydernagar, Hyderabad, Telangana – 500049.

    Final Thoughts

    The Teamtech Formwork Solutions IPO brings forward an intriguing blend of stellar margin profiles and aggressive recent growth. Its firm footing in an infrastructure-hungry economy provides a compelling narrative. However, the premium valuation demands that investors weigh the remarkable FY26 performance against future sustainability metrics. Balancing the strong market dynamics with the inherent risks of SME investing is vital before making capital commitments.